References
Murrin RJ, Murray JA (2006) Thrombotic Thrombocytopenic purpura: aetiology, pathophysiology and treatment. Blood Rev 20:51–60
Schirren CA, Berghaus TM, Sackmann M (1999) Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver failure. Ann Intern Med 130:163
Shibolet O, Kalish Y, Gillis S, Ilan Y (2001) Hepatic and hematological complications following ecstasy usage. Harefuah 140:911–914
Bennett CL, Kim B, Zakarija A et al (2007) Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol 50:1138–1143
Jacob S, Dunn BL, Qureshi ZP et al (2012) Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost 38:845–853
Mauro M, Zlatopolskiy A, Raife TJ, Laurence J (2004) Thienopyridine-linked thrombotic microangiopathy: association with endothelial cell apoptosis and activation of MAP kinase signalling cascades. Br J Haematol 124:200–210
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Fallois, J., Regenthal, R. & Petros, S. Fulminant thrombotic thrombocytopenic purpura (TTP): association with amphetamine consumption?. Ann Hematol 94, 337–338 (2015). https://doi.org/10.1007/s00277-014-2125-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-014-2125-x